The industry backs greater transparency in public summary documents but has warned the current proposed changes risk undermining PBAC decision-making - BioPharmaDispatch explores these concerns and the ramifications.
Industry secures PSD redaction extension after intervention
August 19, 2019 Latest NewsNews of the DayLatest Video
New Stories
-
Stakeholders force Pharmac backdown on move to scrap childhood cancer access program
March 19, 2024 - - Latest News -
ViiV Healthcare Australia announces recipients of 2023 Positive Action Community Grants 
March 19, 2024 - - Latest News -
'I'm a big believer that we as public servants need to engage honestly with our stakeholders'
March 19, 2024 - - Latest News -
A misguided response disconnected from its own history and reality
March 18, 2024 - - Latest News -
Where are the stewards to maintain and protect this critical public health program?
March 18, 2024 - - Latest News -
The fast-finishing AstraZeneca secures Pharma Cup for 2024 Kosi Challenge
March 18, 2024 - - Latest News -
Merck expands fertility benefit for its employees in Australia
March 15, 2024 - - Latest News